HES1, a Target of Notch Signaling, Is Elevated in Canine Osteosarcoma, but Reduced in the Most Aggressive Tumors

BMC Veterinary Research - United Kingdom
doi 10.1186/1746-6148-9-130
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Nuclear ING2 Expression Is Reduced in Osteosarcoma

Oncology Reports
MedicineCancer ResearchOncology
2014English

Dll4-Notch Signaling as a Therapeutic Target in Tumor Angiogenesis

Vascular Cell
Computer NetworksDevelopmental NeuroscienceNeurologyCell BiologyCommunications
2011English

Dual Mechanism of Action of Resveratrol in Notch Signaling Pathway Activation in Osteosarcoma

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2016English

The Growth and Aggressive Behavior of Human Osteosarcoma Is Regulated by a CaMKII-Controlled Autocrine VEGF Signaling Mechanism

PLoS ONE
Multidisciplinary
2015English

Tumor Suppressor Role of Notch-1 Signaling in Neuroendocrine Tumors

Oncologist
Cancer ResearchMedicineOncology
2007English

BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2006English

Author Correction: Notch Signaling Pathway Is a Potential Therapeutic Target for Extracranial Vascular Malformations

Scientific Reports
Multidisciplinary
2020English

CTLA-4 Is a Direct Target of WNT/Β-Catenin Signaling and Is Expressed in Human Melanoma Tumors

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2008English

The Orphan Nuclear Receptor TLX Represses Hes1 Expression, Thereby Affecting NOTCH Signaling and Lineage Progression in the Adult SEZ

Stem Cell Reports
BiochemistryGeneticsDevelopmental BiologyCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy